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Abstract
As healthcare resources become increasingly scarce due to growing demand and stagnating budgets, the need for 
effective priority setting and resource allocation will become ever more critical to providing sustainable care to 
patients. While societal values should certainly play a part in guiding these processes, the methodology used to 
capture these values need not necessarily be limited to multi-criterion decision analysis (MCDA)-based processes 
including ‘evidence-informed deliberative processes.’ However, if decision-makers intend to not only incorporates 
the values of the public they serve into decisions but have the decisions enacted as well, consideration should be 
given to more direct involvement of stakeholders. Based on the examples provided by Baltussen et al, MCDA-based 
processes like ‘evidence-informed deliberative processes’ could be one way of achieving this laudable goal.
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Introduction
As healthcare organizations around the world face a scarcity 
of resources to fund growing demand, the need to set 
priorities to guide allocation is becoming increasingly critical. 
To support this effort, Baltussen et al paper provides an in-
depth discussion of the processes and criteria that should be 
used to guide priority setting. More specifically, they argue 
that restricting criteria to cost-effectiveness does not respect 
the inherently political nature of priority setting itself. As an 
alternative to using cost-effectiveness exclusively, Baltussen et 
al propose using ‘evidence-informed deliberative processes’ to 
guide the criteria development and priority setting process. 
Multiple examples of application are provided including 
HIV Control in Indonesia, and Reimbursement Decisions 
in Health Technology Agencies.1 In this editorial, a re-
examination of Baltussen et al central thesis will be presented 
along with additional commentary related to the use of 
‘evidence-informed deliberative processes.’
To begin, a point of clarification: in Baltussen et al paper, the 
term cost-effectiveness analysis (CEA) appears to be used to 
describe analyses that could include both natural units (eg, 
cancers detected, reduction in blood pressure, falls avoided) 
and utilities in terms of ‘healthy years’ as measures of benefit.1,2 
This covers both the conventional definition of CEA as well as 
cost utility analysis (CUA).2 Both types of analyses are based 
in an extra-welfarist paradigm whereby the benefits and costs 
derived from an intervention are compared against a control 
or current standard of care.2-4 Quality adjusted life years 
(QALYs) have been the widely accepted reference standard 
in CUA, and serve as a measurement of health.2,5 Using an 
incremental cost-effectiveness planes, decisions are made as 
to whether a new intervention should be adopted over the 
current standard of care.2 Standard units (QALYs) allow for 
comparability between distinct interventions, and facilitate 
the allocation of resources based on these results.2 In this way, 
‘health’ could be maximized by funding interventions that 
deliver the greatest value (ie, largest benefit with the smallest 
cost) as determined by the results of these analyses. 
Societal Values
In their argument against the sole use of CEA to guide the 
allocation of resources, Baltussen et al posit that priority 
setting is a “value laden political process, in which multiple 
criteria beyond cost-effectiveness [ie, health or QALY 
maximization] are important.” Social values including “caring 
for the worse off in society or responsibility for one’s own 
health” are provided as examples.1 While they claim that 
this may call for a “paradigm shift in how research should 
approach the challenge of priority setting,” the notion that a 
singular measure of benefit is insufficient to fully capture the 
benefits of an intervention has been – and continues to be – 
grappled with in the realm of CEA methodology.
An early example of this desire to broaden the perspective 
of resource allocation decisions was described by Sen who 
argued that a focus on individual utility via welfare economics 
was too narrow, and “ought to be replaced by an approach 
that took the quality of utility and peoples’ capabilities into 
account.”3,6 Indeed, this rejection of an exclusive focus on 
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individual utility and broadening of the evaluative space to 
include other desiderata including ‘health’ was one of the 
“seeds” from which extra-welfarism and CEA has grown.3 
Further, an acknowledgement of health as a ‘merit good’ or 
‘basic good’ and the need to distribute it equally within a 
society forms another tenet of extra-welfarism.7-9 Since the 
founding of these tenets of extra-welfarism, developments of 
CEA methodology to better capture the benefits of healthcare 
interventions – and reflect the values of a society – have been 
created including: multiple instruments to measure health, 
weighted adjustments, and broader measurement of cost.
While the EQ-5D and SF-6D are two of the traditional 
approaches used to measure QALYs in patients receiving 
interventions, factors including well-being of the patient 
and impact on patients’ families have been incorporated 
into newer instruments to allow for a broader conception 
of health.10-12 Additional measures of utility have also been 
recognized and included in analyses including the experience 
of patients undergoing interventions ie, their process 
utility.13,14 Weighted adjustments of health measurements 
have also been proposed and carried out to more accurately 
reflect the benefits of treatments with respect to a society’s 
preferences. These adjustments have included weighting 
benefit with respect to age and equity. For example, 
attributing more weight to benefits experienced by younger 
patients,15 to older patients,16 to patients of working age,17 to 
those with poor levels of initial health, to those that stand to 
lose a larger proportion of their health, or to those that have 
a lower socioeconomic status.16,18,19 While these approaches 
have focused on redistributing the benefits of interventions, 
attempts to reflect societal values have also been addressed 
when accounting for costs of interventions. For example, 
the inclusion of indirect costs to a society in order to reflect 
the productive contribution of persons at different ages.20 
In this way, societal values and factors could and have been 
quantified and incorporated into CEA to better capture the 
benefits of interventions and reflect societal preferences.21 
While this methodology is certainly not perfect (and 
perhaps never will be), the aforementioned areas of research 
would counter Baltussen et al argument that CEA cannot 
accommodate social values into its calculations. One could 
argue that these methods could even provide a more rigorous 
measurement and analysis of societal values than ‘evidence-
informed deliberative processes’ which rely more heavily 
on expert opinion during “deliberative discussion among 
consultation panel members … to reach agreement on the 
final rank order of interventions.”1 In fact, this concentration 
of power in the hands of a select group on behalf of a 
population has been a criticism of multi-criterion decision 
analysis (MCDA) approaches like ‘evidence-informed 
deliberative processes.’22 
If it is accepted that CEA methodology has some ability to 
capture societal values in its measurement and analysis, 
then this distinction between CEA and ‘evidence-informed 
deliberative processes’ (and all other MCDA processes) lies 
in the methods used to quantify these values – and not in an 
ability or inability to do so. 
Stakeholder Engagement
While Baltussen et al first argument that ‘evidence-informed 
deliberative processes’ are able to capture societal values (while 
CEA methodology cannot) necessitates further discussion, 
their second argument surrounding stakeholder involvement 
in these processes is very compelling from both a theoretical 
and practical standpoint.
Based on the theoretical foundation provided by ‘Procedural 
Justice’ whereby those individuals affected should have the 
opportunity to participate in the decision-making process, 
Baltussen et al cite the work of Daniels and Sabin to support 
their assertion that stakeholders are “more likely to confer 
legitimacy to [a] decision” that emanates from a process 
that has included them meaningfully.1,23 Theoretically, this 
argument is also supported by ‘values-based evaluation’ that 
follows social constructivist ontologies and suggests that 
broader social impacts should be included by considering all 
relevant perspectives in an evaluation.24-26 Engagement from 
staff and the public has also been identified as an element of 
high performance in priority setting and resource allocation 
process, and as facilitator to effective resource allocation in 
other MCDA processes.27,28
While CEA methodology might be able to account for 
societal values (or any other values that might be deemed 
relevant by decision-makers), the collection and analysis of 
data as well as the recommendations delivered to decision-
makers will likely be conducted by investigators or scientists 
rather than stakeholders. Although this may allow for more 
rigorous methods of valuation, the results may encounter 
greater resistance since the stakeholders who are impacted by 
the changes were not directly involved in the process. 
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